ArticleBJU international2021

Two cycles of neoadjuvant chemotherapy improves survival in patients with high-risk upper tract urothelial carcinoma.

Kenji Zennami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.